Low-Dose Orlistat Effects on Body Weight of Mildly to Moderately Overweight Individuals: A 16 Week, Double-Blind, Placebo-Controlled Trial
Ann Pharmacother Anderson et al.
40: 1717
Low-Dose Orlistat Effects on Body Weight of Mildly to Moderately Overweight Individuals: A 16 Week, Double-Blind, Placebo-Controlled Trial
“For Our Patients” is a service provided by The Annals of Pharmacotherapy to help you understand the latest research developments and clinical information that relate to medications that have been prescribed for you. These summaries are for informational purposes only.
Files in this Data Supplement: